Abstract Neointimal hyperplasia is a major cause of restenosis and graft failure after vascular interventions. Perivascular drug delivery offers a potential solution, but achieving sustained and condition-dependent release at injured sites remains challenging. Here, we developed an injectable hydrogel with pH-sensitive and protease-susceptible characteristics (OHA-CS/GelMA) encapsulating rapamycin-loaded liposomes (Rapa-Lipo@Gel).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Mingdong
Contact Mingdong, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack